Click for best price
Bipolar Disorder Drugs Treatment Market Size, Share 2022
Drug therapy is currently the core method of treating bipolar disorder, that is, the use of emotional stabilizers to adjust the patient's mood. Bipolar disorder is complex and difficult to control. The drug effect of emotional stabilizers can help patients to suppress their emotions when they are too high, to increase their emotions when they are depressed, to stabilize their emotions at a normal level, and to effectively prevent the recurrence of bipolar disorder. The quickest and most effective approach may be convulsive-free electroconvulsive therapy.
This report contains market size and forecasts of Bipolar Disorder Drugs and Treatment in global, including the following market information:
Global Bipolar Disorder Drugs and Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Bipolar Disorder Drugs and Treatment Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Bipolar Disorder Drugs and Treatment companies in 2021 (%)
The global Bipolar Disorder Drugs and Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Mood Stabilizers Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Bipolar Disorder Drugs and Treatment include AbbVie Inc., Glaxo SmithKline (GSK), Eli Lily and Company, Janssen Pharmaceuticals, Johnson & Johnson, Astellas Pharma Inc, Bristol Myers Squibb, Gedeon Richter PLC. and H. Lundbeck A/S, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Bipolar Disorder Drugs and Treatment manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Bipolar Disorder Drugs and Treatment Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Bipolar Disorder Drugs and Treatment Market Segment Percentages, by Type, 2021 (%)
Mood Stabilizers
Anticonvulsants
Antipsychotic Drugs
Antidepressant Drugs
Anti-Anxiety Drugs
Global Bipolar Disorder Drugs and Treatment Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Bipolar Disorder Drugs and Treatment Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Global Bipolar Disorder Drugs and Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Bipolar Disorder Drugs and Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Bipolar Disorder Drugs and Treatment revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Bipolar Disorder Drugs and Treatment revenues share in global market, 2021 (%)
Key companies Bipolar Disorder Drugs and Treatment sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Bipolar Disorder Drugs and Treatment sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AbbVie Inc.
Glaxo SmithKline (GSK)
Eli Lily and Company
Janssen Pharmaceuticals
Johnson & Johnson
Astellas Pharma Inc
Bristol Myers Squibb
Gedeon Richter PLC.
H. Lundbeck A/S
Pfizer Inc.
Novartis AG
Otsuka Holdings Co. Ltd
Validus Pharmaceuticals LLC.
| Report Attributes |
Report Details |
| Report Title |
Bipolar Disorder Drugs and Treatment Market, Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
75 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Bipolar Disorder Drugs and Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Bipolar Disorder Drugs and Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Bipolar Disorder Drugs and Treatment Overall Market Size
2.1 Global Bipolar Disorder Drugs and Treatment Market Size: 2021 VS 2028
2.2 Global Bipolar Disorder Drugs and Treatment Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Bipolar Disorder Drugs and Treatment Sales: 2017-2028
3 Company Landscape
3.1 Top Bipolar Disorder Drugs and Treatment Players in Global Market
3.2 Top Global Bipolar Disorder Drugs and Treatment Companies Ranked by Revenue
3.3 Global Bipolar Disorder Drugs and Treatment Revenue by Companies
3.4 Global Bipolar Disorder Drugs and Treatment Sales by Companies
3.5 Global Bipolar Disorder Drugs and Treatment Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Bipolar Disorder Drugs and Treatment Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Bipolar Disorder Drugs and Treatment Product Type
3.8 Tier 1, Tier 2 and Tier 3 Bipolar Disorder Drugs and Treatment Players in Global Market
3.8.1 List of Global Tier 1 Bipolar Disorder Drugs and Treatment Companies
3.8.2 List of Global Tier 2 and Tier 3 Bipolar Disorder Drugs and Treatment Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Bipolar Disorder Drugs and Treatment Market Size Markets, 2021 & 2028
4.1.2 Mood Stabilizers
4.1.3 Anticonvulsants
4.1.4 Antipsychotic Drugs
4.1.5 Antidepressant Drugs
4.1.6 Anti-Anxiety Drugs
4.2 By Type - Global Bipolar Disorder Drugs and Treatment Revenue & Forecasts
4.2.1 By Type - Global Bipolar Disorder Drugs and Treatment Revenue, 2017-2022
4.2.2 By Type - Global Bipolar Disorder Drugs and Treatment Revenue, 2023-2028
4.2.3 By Type - Global Bipolar Disorder Drugs and Treatment Revenue Market Share, 2017-2028
4.3 By Type - Global Bipolar Disorder Drugs and Treatment Sales & Forecasts
4.3.1 By Type - Global Bipolar Disorder Drugs and Treatment Sales, 2017-2022
4.3.2 By Type - Global Bipolar Disorder Drugs and Treatment Sales, 2023-2028
4.3.3 By Type - Global Bipolar Disorder Drugs and Treatment Sales Market Share, 2017-2028
4.4 By Type - Global Bipolar Disorder Drugs and Treatment Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Bipolar Disorder Drugs and Treatment Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Clinic
5.2 By Application - Global Bipolar Disorder Drugs and Treatment Revenue & Forecasts
5.2.1 By Application - Global Bipolar Disorder Drugs and Treatment Revenue, 2017-2022
5.2.2 By Application - Global Bipolar Disorder Drugs and Treatment Revenue, 2023-2028
5.2.3 By Application - Global Bipolar Disorder Drugs and Treatment Revenue Market Share, 2017-2028
5.3 By Application - Global Bipolar Disorder Drugs and Treatment Sales & Forecasts
5.3.1 By Application - Global Bipolar Disorder Drugs and Treatment Sales, 2017-2022
5.3.2 By Application - Global Bipolar Disorder Drugs and Treatment Sales, 2023-2028
5.3.3 By Application - Global Bipolar Disorder Drugs and Treatment Sales Market Share, 2017-2028
5.4 By Application - Global Bipolar Disorder Drugs and Treatment Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Bipolar Disorder Drugs and Treatment Market Size, 2021 & 2028
6.2 By Region - Global Bipolar Disorder Drugs and Treatment Revenue & Forecasts
6.2.1 By Region - Global Bipolar Disorder Drugs and Treatment Revenue, 2017-2022
6.2.2 By Region - Global Bipolar Disorder Drugs and Treatment Revenue, 2023-2028
6.2.3 By Region - Global Bipolar Disorder Drugs and Treatment Revenue Market Share, 2017-2028
6.3 By Region - Global Bipolar Disorder Drugs and Treatment Sales & Forecasts
6.3.1 By Region - Global Bipolar Disorder Drugs and Treatment Sales, 2017-2022
6.3.2 By Region - Global Bipolar Disorder Drugs and Treatment Sales, 2023-2028
6.3.3 By Region - Global Bipolar Disorder Drugs and Treatment Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Bipolar Disorder Drugs and Treatment Revenue, 2017-2028
6.4.2 By Country - North America Bipolar Disorder Drugs and Treatment Sales, 2017-2028
6.4.3 US Bipolar Disorder Drugs and Treatment Market Size, 2017-2028
6.4.4 Canada Bipolar Disorder Drugs and Treatment Market Size, 2017-2028
6.4.5 Mexico Bipolar Disorder Drugs and Treatment Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Bipolar Disorder Drugs and Treatment Revenue, 2017-2028
6.5.2 By Country - Europe Bipolar Disorder Drugs and Treatment Sales, 2017-2028
6.5.3 Germany Bipolar Disorder Drugs and Treatment Market Size, 2017-2028
6.5.4 France Bipolar Disorder Drugs and Treatment Market Size, 2017-2028
6.5.5 U.K. Bipolar Disorder Drugs and Treatment Market Size, 2017-2028
6.5.6 Italy Bipolar Disorder Drugs and Treatment Market Size, 2017-2028
6.5.7 Russia Bipolar Disorder Drugs and Treatment Market Size, 2017-2028
6.5.8 Nordic Countries Bipolar Disorder Drugs and Treatment Market Size, 2017-2028
6.5.9 Benelux Bipolar Disorder Drugs and Treatment Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Bipolar Disorder Drugs and Treatment Revenue, 2017-2028
6.6.2 By Region - Asia Bipolar Disorder Drugs and Treatment Sales, 2017-2028
6.6.3 China Bipolar Disorder Drugs and Treatment Market Size, 2017-2028
6.6.4 Japan Bipolar Disorder Drugs and Treatment Market Size, 2017-2028
6.6.5 South Korea Bipolar Disorder Drugs and Treatment Market Size, 2017-2028
6.6.6 Southeast Asia Bipolar Disorder Drugs and Treatment Market Size, 2017-2028
6.6.7 India Bipolar Disorder Drugs and Treatment Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Bipolar Disorder Drugs and Treatment Revenue, 2017-2028
6.7.2 By Country - South America Bipolar Disorder Drugs and Treatment Sales, 2017-2028
6.7.3 Brazil Bipolar Disorder Drugs and Treatment Market Size, 2017-2028
6.7.4 Argentina Bipolar Disorder Drugs and Treatment Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Bipolar Disorder Drugs and Treatment Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Bipolar Disorder Drugs and Treatment Sales, 2017-2028
6.8.3 Turkey Bipolar Disorder Drugs and Treatment Market Size, 2017-2028
6.8.4 Israel Bipolar Disorder Drugs and Treatment Market Size, 2017-2028
6.8.5 Saudi Arabia Bipolar Disorder Drugs and Treatment Market Size, 2017-2028
6.8.6 UAE Bipolar Disorder Drugs and Treatment Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 AbbVie Inc.
7.1.1 AbbVie Inc. Corporate Summary
7.1.2 AbbVie Inc. Business Overview
7.1.3 AbbVie Inc. Bipolar Disorder Drugs and Treatment Major Product Offerings
7.1.4 AbbVie Inc. Bipolar Disorder Drugs and Treatment Sales and Revenue in Global (2017-2022)
7.1.5 AbbVie Inc. Key News
7.2 Glaxo SmithKline (GSK)
7.2.1 Glaxo SmithKline (GSK) Corporate Summary
7.2.2 Glaxo SmithKline (GSK) Business Overview
7.2.3 Glaxo SmithKline (GSK) Bipolar Disorder Drugs and Treatment Major Product Offerings
7.2.4 Glaxo SmithKline (GSK) Bipolar Disorder Drugs and Treatment Sales and Revenue in Global (2017-2022)
7.2.5 Glaxo SmithKline (GSK) Key News
7.3 Eli Lily and Company
7.3.1 Eli Lily and Company Corporate Summary
7.3.2 Eli Lily and Company Business Overview
7.3.3 Eli Lily and Company Bipolar Disorder Drugs and Treatment Major Product Offerings
7.3.4 Eli Lily and Company Bipolar Disorder Drugs and Treatment Sales and Revenue in Global (2017-2022)
7.3.5 Eli Lily and Company Key News
7.4 Janssen Pharmaceuticals
7.4.1 Janssen Pharmaceuticals Corporate Summary
7.4.2 Janssen Pharmaceuticals Business Overview
7.4.3 Janssen Pharmaceuticals Bipolar Disorder Drugs and Treatment Major Product Offerings
7.4.4 Janssen Pharmaceuticals Bipolar Disorder Drugs and Treatment Sales and Revenue in Global (2017-2022)
7.4.5 Janssen Pharmaceuticals Key News
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Corporate Summary
7.5.2 Johnson & Johnson Business Overview
7.5.3 Johnson & Johnson Bipolar Disorder Drugs and Treatment Major Product Offerings
7.5.4 Johnson & Johnson Bipolar Disorder Drugs and Treatment Sales and Revenue in Global (2017-2022)
7.5.5 Johnson & Johnson Key News
7.6 Astellas Pharma Inc
7.6.1 Astellas Pharma Inc Corporate Summary
7.6.2 Astellas Pharma Inc Business Overview
7.6.3 Astellas Pharma Inc Bipolar Disorder Drugs and Treatment Major Product Offerings
7.6.4 Astellas Pharma Inc Bipolar Disorder Drugs and Treatment Sales and Revenue in Global (2017-2022)
7.6.5 Astellas Pharma Inc Key News
7.7 Bristol Myers Squibb
7.7.1 Bristol Myers Squibb Corporate Summary
7.7.2 Bristol Myers Squibb Business Overview
7.7.3 Bristol Myers Squibb Bipolar Disorder Drugs and Treatment Major Product Offerings
7.7.4 Bristol Myers Squibb Bipolar Disorder Drugs and Treatment Sales and Revenue in Global (2017-2022)
7.7.5 Bristol Myers Squibb Key News
7.8 Gedeon Richter PLC.
7.8.1 Gedeon Richter PLC. Corporate Summary
7.8.2 Gedeon Richter PLC. Business Overview
7.8.3 Gedeon Richter PLC. Bipolar Disorder Drugs and Treatment Major Product Offerings
7.8.4 Gedeon Richter PLC. Bipolar Disorder Drugs and Treatment Sales and Revenue in Global (2017-2022)
7.8.5 Gedeon Richter PLC. Key News
7.9 H. Lundbeck A/S
7.9.1 H. Lundbeck A/S Corporate Summary
7.9.2 H. Lundbeck A/S Business Overview
7.9.3 H. Lundbeck A/S Bipolar Disorder Drugs and Treatment Major Product Offerings
7.9.4 H. Lundbeck A/S Bipolar Disorder Drugs and Treatment Sales and Revenue in Global (2017-2022)
7.9.5 H. Lundbeck A/S Key News
7.10 Pfizer Inc.
7.10.1 Pfizer Inc. Corporate Summary
7.10.2 Pfizer Inc. Business Overview
7.10.3 Pfizer Inc. Bipolar Disorder Drugs and Treatment Major Product Offerings
7.10.4 Pfizer Inc. Bipolar Disorder Drugs and Treatment Sales and Revenue in Global (2017-2022)
7.10.5 Pfizer Inc. Key News
7.11 Novartis AG
7.11.1 Novartis AG Corporate Summary
7.11.2 Novartis AG Bipolar Disorder Drugs and Treatment Business Overview
7.11.3 Novartis AG Bipolar Disorder Drugs and Treatment Major Product Offerings
7.11.4 Novartis AG Bipolar Disorder Drugs and Treatment Sales and Revenue in Global (2017-2022)
7.11.5 Novartis AG Key News
7.12 Otsuka Holdings Co. Ltd
7.12.1 Otsuka Holdings Co. Ltd Corporate Summary
7.12.2 Otsuka Holdings Co. Ltd Bipolar Disorder Drugs and Treatment Business Overview
7.12.3 Otsuka Holdings Co. Ltd Bipolar Disorder Drugs and Treatment Major Product Offerings
7.12.4 Otsuka Holdings Co. Ltd Bipolar Disorder Drugs and Treatment Sales and Revenue in Global (2017-2022)
7.12.5 Otsuka Holdings Co. Ltd Key News
7.13 Validus Pharmaceuticals LLC.
7.13.1 Validus Pharmaceuticals LLC. Corporate Summary
7.13.2 Validus Pharmaceuticals LLC. Bipolar Disorder Drugs and Treatment Business Overview
7.13.3 Validus Pharmaceuticals LLC. Bipolar Disorder Drugs and Treatment Major Product Offerings
7.13.4 Validus Pharmaceuticals LLC. Bipolar Disorder Drugs and Treatment Sales and Revenue in Global (2017-2022)
7.13.5 Validus Pharmaceuticals LLC. Key News
8 Global Bipolar Disorder Drugs and Treatment Production Capacity, Analysis
8.1 Global Bipolar Disorder Drugs and Treatment Production Capacity, 2017-2028
8.2 Bipolar Disorder Drugs and Treatment Production Capacity of Key Manufacturers in Global Market
8.3 Global Bipolar Disorder Drugs and Treatment Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Bipolar Disorder Drugs and Treatment Supply Chain Analysis
10.1 Bipolar Disorder Drugs and Treatment Industry Value Chain
10.2 Bipolar Disorder Drugs and Treatment Upstream Market
10.3 Bipolar Disorder Drugs and Treatment Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Bipolar Disorder Drugs and Treatment Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Bipolar Disorder Drugs and Treatment in Global Market
Table 2. Top Bipolar Disorder Drugs and Treatment Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Bipolar Disorder Drugs and Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Bipolar Disorder Drugs and Treatment Revenue Share by Companies, 2017-2022
Table 5. Global Bipolar Disorder Drugs and Treatment Sales by Companies, (K Units), 2017-2022
Table 6. Global Bipolar Disorder Drugs and Treatment Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Bipolar Disorder Drugs and Treatment Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Bipolar Disorder Drugs and Treatment Product Type
Table 9. List of Global Tier 1 Bipolar Disorder Drugs and Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Bipolar Disorder Drugs and Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Bipolar Disorder Drugs and Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Bipolar Disorder Drugs and Treatment Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Bipolar Disorder Drugs and Treatment Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Bipolar Disorder Drugs and Treatment Sales (K Units), 2017-2022
Table 15. By Type - Global Bipolar Disorder Drugs and Treatment Sales (K Units), 2023-2028
Table 16. By Application ? Global Bipolar Disorder Drugs and Treatment Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Bipolar Disorder Drugs and Treatment Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Bipolar Disorder Drugs and Treatment Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Bipolar Disorder Drugs and Treatment Sales (K Units), 2017-2022
Table 20. By Application - Global Bipolar Disorder Drugs and Treatment Sales (K Units), 2023-2028
Table 21. By Region ? Global Bipolar Disorder Drugs and Treatment Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Bipolar Disorder Drugs and Treatment Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Bipolar Disorder Drugs and Treatment Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Bipolar Disorder Drugs and Treatment Sales (K Units), 2017-2022
Table 25. By Region - Global Bipolar Disorder Drugs and Treatment Sales (K Units), 2023-2028
Table 26. By Country - North America Bipolar Disorder Drugs and Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Bipolar Disorder Drugs and Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Bipolar Disorder Drugs and Treatment Sales, (K Units), 2017-2022
Table 29. By Country - North America Bipolar Disorder Drugs and Treatment Sales, (K Units), 2023-2028
Table 30. By Country - Europe Bipolar Disorder Drugs and Treatment Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Bipolar Disorder Drugs and Treatment Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Bipolar Disorder Drugs and Treatment Sales, (K Units), 2017-2022
Table 33. By Country - Europe Bipolar Disorder Drugs and Treatment Sales, (K Units), 2023-2028
Table 34. By Region - Asia Bipolar Disorder Drugs and Treatment Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Bipolar Disorder Drugs and Treatment Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Bipolar Disorder Drugs and Treatment Sales, (K Units), 2017-2022
Table 37. By Region - Asia Bipolar Disorder Drugs and Treatment Sales, (K Units), 2023-2028
Table 38. By Country - South America Bipolar Disorder Drugs and Treatment Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Bipolar Disorder Drugs and Treatment Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Bipolar Disorder Drugs and Treatment Sales, (K Units), 2017-2022
Table 41. By Country - South America Bipolar Disorder Drugs and Treatment Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Bipolar Disorder Drugs and Treatment Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Bipolar Disorder Drugs and Treatment Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Bipolar Disorder Drugs and Treatment Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Bipolar Disorder Drugs and Treatment Sales, (K Units), 2023-2028
Table 46. AbbVie Inc. Corporate Summary
Table 47. AbbVie Inc. Bipolar Disorder Drugs and Treatment Product Offerings
Table 48. AbbVie Inc. Bipolar Disorder Drugs and Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Glaxo SmithKline (GSK) Corporate Summary
Table 50. Glaxo SmithKline (GSK) Bipolar Disorder Drugs and Treatment Product Offerings
Table 51. Glaxo SmithKline (GSK) Bipolar Disorder Drugs and Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Eli Lily and Company Corporate Summary
Table 53. Eli Lily and Company Bipolar Disorder Drugs and Treatment Product Offerings
Table 54. Eli Lily and Company Bipolar Disorder Drugs and Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Janssen Pharmaceuticals Corporate Summary
Table 56. Janssen Pharmaceuticals Bipolar Disorder Drugs and Treatment Product Offerings
Table 57. Janssen Pharmaceuticals Bipolar Disorder Drugs and Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Johnson & Johnson Corporate Summary
Table 59. Johnson & Johnson Bipolar Disorder Drugs and Treatment Product Offerings
Table 60. Johnson & Johnson Bipolar Disorder Drugs and Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Astellas Pharma Inc Corporate Summary
Table 62. Astellas Pharma Inc Bipolar Disorder Drugs and Treatment Product Offerings
Table 63. Astellas Pharma Inc Bipolar Disorder Drugs and Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Bristol Myers Squibb Corporate Summary
Table 65. Bristol Myers Squibb Bipolar Disorder Drugs and Treatment Product Offerings
Table 66. Bristol Myers Squibb Bipolar Disorder Drugs and Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. Gedeon Richter PLC. Corporate Summary
Table 68. Gedeon Richter PLC. Bipolar Disorder Drugs and Treatment Product Offerings
Table 69. Gedeon Richter PLC. Bipolar Disorder Drugs and Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. H. Lundbeck A/S Corporate Summary
Table 71. H. Lundbeck A/S Bipolar Disorder Drugs and Treatment Product Offerings
Table 72. H. Lundbeck A/S Bipolar Disorder Drugs and Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. Pfizer Inc. Corporate Summary
Table 74. Pfizer Inc. Bipolar Disorder Drugs and Treatment Product Offerings
Table 75. Pfizer Inc. Bipolar Disorder Drugs and Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. Novartis AG Corporate Summary
Table 77. Novartis AG Bipolar Disorder Drugs and Treatment Product Offerings
Table 78. Novartis AG Bipolar Disorder Drugs and Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 79. Otsuka Holdings Co. Ltd Corporate Summary
Table 80. Otsuka Holdings Co. Ltd Bipolar Disorder Drugs and Treatment Product Offerings
Table 81. Otsuka Holdings Co. Ltd Bipolar Disorder Drugs and Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 82. Validus Pharmaceuticals LLC. Corporate Summary
Table 83. Validus Pharmaceuticals LLC. Bipolar Disorder Drugs and Treatment Product Offerings
Table 84. Validus Pharmaceuticals LLC. Bipolar Disorder Drugs and Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 85. Bipolar Disorder Drugs and Treatment Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 86. Global Bipolar Disorder Drugs and Treatment Capacity Market Share of Key Manufacturers, 2020-2022
Table 87. Global Bipolar Disorder Drugs and Treatment Production by Region, 2017-2022 (K Units)
Table 88. Global Bipolar Disorder Drugs and Treatment Production by Region, 2023-2028 (K Units)
Table 89. Bipolar Disorder Drugs and Treatment Market Opportunities & Trends in Global Market
Table 90. Bipolar Disorder Drugs and Treatment Market Drivers in Global Market
Table 91. Bipolar Disorder Drugs and Treatment Market Restraints in Global Market
Table 92. Bipolar Disorder Drugs and Treatment Raw Materials
Table 93. Bipolar Disorder Drugs and Treatment Raw Materials Suppliers in Global Market
Table 94. Typical Bipolar Disorder Drugs and Treatment Downstream
Table 95. Bipolar Disorder Drugs and Treatment Downstream Clients in Global Market
Table 96. Bipolar Disorder Drugs and Treatment Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Bipolar Disorder Drugs and Treatment Segment by Type
Figure 2. Bipolar Disorder Drugs and Treatment Segment by Application
Figure 3. Global Bipolar Disorder Drugs and Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Bipolar Disorder Drugs and Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Bipolar Disorder Drugs and Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. Bipolar Disorder Drugs and Treatment Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Bipolar Disorder Drugs and Treatment Revenue in 2021
Figure 9. By Type - Global Bipolar Disorder Drugs and Treatment Sales Market Share, 2017-2028
Figure 10. By Type - Global Bipolar Disorder Drugs and Treatment Revenue Market Share, 2017-2028
Figure 11. By Type - Global Bipolar Disorder Drugs and Treatment Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Bipolar Disorder Drugs and Treatment Sales Market Share, 2017-2028
Figure 13. By Application - Global Bipolar Disorder Drugs and Treatment Revenue Market Share, 2017-2028
Figure 14. By Application - Global Bipolar Disorder Drugs and Treatment Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Bipolar Disorder Drugs and Treatment Sales Market Share, 2017-2028
Figure 16. By Region - Global Bipolar Disorder Drugs and Treatment Revenue Market Share, 2017-2028
Figure 17. By Country - North America Bipolar Disorder Drugs and Treatment Revenue Market Share, 2017-2028
Figure 18. By Country - North America Bipolar Disorder Drugs and Treatment Sales Market Share, 2017-2028
Figure 19. US Bipolar Disorder Drugs and Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Bipolar Disorder Drugs and Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Bipolar Disorder Drugs and Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Bipolar Disorder Drugs and Treatment Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Bipolar Disorder Drugs and Treatment Sales Market Share, 2017-2028
Figure 24. Germany Bipolar Disorder Drugs and Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. France Bipolar Disorder Drugs and Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Bipolar Disorder Drugs and Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Bipolar Disorder Drugs and Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Bipolar Disorder Drugs and Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Bipolar Disorder Drugs and Treatment Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Bipolar Disorder Drugs and Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Bipolar Disorder Drugs and Treatment Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Bipolar Disorder Drugs and Treatment Sales Market Share, 2017-2028
Figure 33. China Bipolar Disorder Drugs and Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Bipolar Disorder Drugs and Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Bipolar Disorder Drugs and Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Bipolar Disorder Drugs and Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. India Bipolar Disorder Drugs and Treatment Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Bipolar Disorder Drugs and Treatment Revenue Market Share, 2017-2028
Figure 39. By Country - South America Bipolar Disorder Drugs and Treatment Sales Market Share, 2017-2028
Figure 40. Brazil Bipolar Disorder Drugs and Treatment Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Bipolar Disorder Drugs and Treatment Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Bipolar Disorder Drugs and Treatment Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Bipolar Disorder Drugs and Treatment Sales Market Share, 2017-2028
Figure 44. Turkey Bipolar Disorder Drugs and Treatment Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Bipolar Disorder Drugs and Treatment Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Bipolar Disorder Drugs and Treatment Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Bipolar Disorder Drugs and Treatment Revenue, (US$, Mn), 2017-2028
Figure 48. Global Bipolar Disorder Drugs and Treatment Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Bipolar Disorder Drugs and Treatment by Region, 2021 VS 2028
Figure 50. Bipolar Disorder Drugs and Treatment Industry Value Chain
Figure 51. Marketing Channels
